---
title: "Pioglitazone - Diabetes mellitus type 2"
sidebar: mydoc_sidebar
permalink: pioglitazonediabetesmellitustype23.html
toc: false 
---

{% include image.html file="pioglitazonediabetesmellitustype23.png" alt="pioglitazonediabetesmellitustype23" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| DB:DB01132 | Pioglitazone | Drug |
| UniProt:P37231 | peroxisome proliferator-activated receptor-gamma | Protein |
| GO:0032869 | tissue sensitivity to insulin | BiologicalProcess |
| GO:0001951 | uptake of blood glucose | BiologicalProcess |
| MESH:D001786 | glycated hemoglobin | ChemicalSubstance |
| MESH:D003924 | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Pioglitazone | INCREASES ACTIVITY OF | Peroxisome Proliferator-Activated Receptor-Gamma |
| Peroxisome Proliferator-Activated Receptor-Gamma | POSITIVELY REGULATES | Tissue Sensitivity To Insulin |
| Tissue Sensitivity To Insulin | INCREASES RESPONSE TO | Uptake Of Blood Glucose |
| Uptake Of Blood Glucose | DECREASES ABUNDANCE OF | Glycated Hemoglobin |
| Glycated Hemoglobin | CORRELATED WITH | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB01132#mechanism-of-action](https://go.drugbank.com/drugs/DB01132#mechanism-of-action){:target="_blank"}